Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,187.00    -13.00 (-1.08%)
Bid:
1,188.00
Ask:
1,190.00
Spread: 2.00 (0.168%)
Market Cap: £825.47m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Total Voting Rights

2 Sep 2024 14:45

RNS Number : 5747C
CVS Group plc
02 September 2024
 

2 September 2024

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Total Voting Rights

 

CVS, one of the UK's leading providers of integrated veterinary services, confirms that certain employees have exercised options during August under the CVS Group 2020 SAYE Plan (2020/2024) totalling 623 ordinary shares of 0.2 pence each ("Ordinary Shares").

The sum of 623 new Ordinary Shares were issued to satisfy the balance of Ordinary Shares arising from the SAYE Exercise. Admission of the 623 new Ordinary Shares has been satisfied by the Company's block listing admitted to the London Stock Exchange on 30 December 2021. 

Following the issue of these new Ordinary Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, the Company has a total issued share capital of 71,738,224 Ordinary Shares, each carrying one voting right. The Company holds no Ordinary Shares in treasury and the total number of voting rights is therefore 71,738,224.

This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Contacts:

CVS Group plc via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

  About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in the UK, and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.460 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties), Crematoria (providing pet cremation and clinical waste disposal for CVS and third-party practices) and an online retail business ("Animed Direct").

 

The Group employs c.9,000 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRQKBBQNBKDNCK
Date   Source Headline
27th Sep 20117:00 amRNSPreliminary Results
22nd Sep 20114:01 pmRNSHolding(s) in Company
25th Jul 20117:00 amRNSTrading update and Acquisitions
18th Jul 20117:00 amRNSLTIP Award
24th May 201111:37 amRNSHolding(s) in Company
16th May 201110:17 amRNSHolding(s) in Company
11th May 20113:57 pmRNSHolding(s) in Company
11th May 20112:41 pmRNSHolding(s) in Company
11th May 20112:01 pmRNSHolding(s) in Company
10th May 20117:00 amRNSHolding(s) in Company
4th May 201111:24 amRNSHolding(s) in Company
19th Apr 201111:45 amRNSHolding(s) in Company
6th Apr 20113:34 pmRNSHolding(s) in Company
18th Mar 20114:23 pmRNSHolding(s) in Company
17th Mar 20117:00 amRNSInterim results
7th Feb 20117:00 amRNSNotice of Results
31st Dec 20107:00 amRNSTotal Voting Rights
22nd Dec 201010:46 amRNSPosting of Annual Report
21st Dec 20104:30 pmRNSHolding(s) in Company
17th Dec 20104:40 pmRNSSecond Price Monitoring Extn
17th Dec 20104:35 pmRNSPrice Monitoring Extension
16th Dec 201012:05 pmRNSDirector/PDMR Shareholding
10th Dec 201011:13 amRNSExercise of Share Options under LTIP
10th Dec 20107:00 amRNSDirector Resignation
9th Dec 20101:58 pmRNSResult of AGM
16th Nov 20107:00 amRNSAcquisition
14th Oct 201010:50 amRNSHolding(s) in Company
7th Oct 20101:59 pmRNSLTIP Award
6th Oct 201010:34 amRNSHolding(s) in Company
5th Oct 201011:42 amRNSHolding(s) in Company
5th Oct 20107:00 amRNSPreliminary Results
27th Aug 20104:06 pmRNSHolding(s) in Company
13th Aug 20104:17 pmRNSHolding(s) in Company
30th Jul 201010:23 amRNSNotification of Preliminary Results
26th Jul 20103:19 pmRNSHolding(s) in Company
2nd Jul 20107:00 amRNSDirector/PDMR Shareholding
29th Jun 20107:00 amRNSTrading Update & Acquisitions
25th Jun 201011:33 amRNSHolding(s) in Company
21st Jun 20109:39 amRNSHolding(s) in Company
24th May 201010:36 amRNSHolding(s) in Company
19th May 201011:43 amRNSHolding(s) in Company
19th May 20107:00 amRNSAcquisition & Trading Update
21st Apr 201012:11 pmRNSHolding(s) in Company
31st Mar 201012:43 pmRNSTotal Voting Rights
23rd Mar 20107:00 amRNSAcquisition of veterinary group
16th Mar 20107:00 amRNSAcquisition
15th Mar 20104:14 pmRNSHolding(s) in Company
10th Mar 201011:10 amRNSResult of GM
9th Mar 201010:32 amRNSHolding(s) in Company
19th Feb 20104:21 pmRNSAnalyst Conference Call

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.